Patent ID: 11938246
Assignee: FETTECH, LLC
Field: Medical technology (Instruments)
Classification: CPC A | IPC A

Claim 14:
15. A composition comprising:
spleen extracellular matrix in particulate form, wherein the spleen extracellular matrix comprises native epidermal growth factor retained from spleen tissue; and
lung extracellular matrix in particulate form, wherein the lung extracellular matrix comprises native epidermal growth factor retained from lung tissue;
wherein the spleen extracellular matrix has a different concentration of epidermal growth factor than the second extracellular matrix, and the second extracellular matrix has a different concentration of elastin than the spleen extracellular matrix;
wherein the composition comprises about 6.1 ng/mg to about 12.5 ng/mg of epidermal growth factor;
wherein the particles of spleen extracellular matrix and the particles of lung extracellular matrix range from about 1 nm to about 5 μm in diameter; and
wherein the composition is formulated for application onto or into a site of defect or wound of a patient via inhalation.